Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

IRF3 and type I interferons fuel a fatal response to myocardial infarction

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Mus musculus

PROVIDER: GSE106473 | GEO | 2017/11/06

SECONDARY ACCESSION(S): PRJNA416978

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

IRF3 and type I interferons fuel a fatal response to myocardial infarction.

Project description: Not available

| S-EPMC6477926 | biostudies-literature

IRF3 and type I interferons fuel a fatal response to myocardial infarction [bulk RNA-Seq]

Project description:Interferon regulatory factor 3 (IRF3) and type I interferons (IFNs) protect against infections1 and cancer2, but excessive IRF3 activation and type I IFN production cause autoinflammatory conditions such as Aicardi?Goutières syndrome3,4 and STING-associated vasculopathy of infancy (SAVI)3. Myocardial infarction (MI) elicits inflammation5, but the dominant molecular drivers of MI-associated inflammation remain unclear. Here we show that ischemic cell death and uptake of cell debris by macrophages in the heart fuel a fatal response to MI by activating IRF3 and type I IFN production. In mice, single-cell RNA-seq analysis of 4,215 leukocytes isolated from infarcted and non-infarcted hearts showed that MI provokes activation of an IRF3?interferon axis in a distinct population of interferon-inducible cells (IFNICs) that were classified as cardiac macrophages. Mice genetically deficient in cyclic GMP-AMP synthase (cGAS), its adaptor STING, IRF3, or the type I IFN receptor IFNAR exhibited impaired interferon-stimulated gene (ISG) expression and, in the case of mice deficient in IRF3 or IFNAR, improved survival after MI as compared to controls. Interruption of IRF3-dependent signaling resulted in decreased cardiac expression of inflammatory cytokines and chemokines and decreased inflammatory cell infiltration of the heart, as well as in attenuated ventricular dilation and improved cardiac function. Similarly, treatment of mice with an IFNAR-neutralizing antibody after MI ablated the interferon response and improved left ventricular dysfunction and survival. These results identify IRF3 and the type I IFN response as a potential therapeutic target for post-MI cardioprotection.

2017-11-06 | GSE106471 | GEO

IRF3 and type I interferons fuel a fatal response to myocardial infarction [single cell RNA-Seq]

2017-11-06 | GSE106472 | GEO

IRF3 and type I interferons fuel a fatal response to myocardial infarction

Project description:IRF3 and type I interferons fuel a fatal response to myocardial infarction

| PRJNA416978 | ENA

IRF3 and type I interferons fuel a fatal response to myocardial infarction [bulk RNA-Seq]

Project description:IRF3 and type I interferons fuel a fatal response to myocardial infarction [bulk RNA-Seq]

| PRJNA417168 | ENA

IRF3 and type I interferons fuel a fatal response to myocardial infarction [single cell RNA-Seq]

Project description:IRF3 and type I interferons fuel a fatal response to myocardial infarction [single cell RNA-Seq]

| PRJNA417199 | ENA

miRNA expression data from the hearts of myocardial infarction model

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2016-01-07 | E-GEOD-76604 | biostudies-arrayexpress

Identification of Novel Serum Biomarkers for Early Decision of ST-elevation Myocardial Infarction

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2015-05-23 | E-GEOD-61145 | biostudies-arrayexpress

Myocardial Infarction accelerates breast cancer via innate immune reprogramming

Project description:This SuperSeries is composed of the SubSeries listed below.

2020-06-11 | GSE137790 | GEO

Sex differences in neutrophil biology modulate response to type I Interferons and immunometabolism

Project description:This SuperSeries is composed of the SubSeries listed below.

2020-06-29 | GSE145231 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data